Franco S, Szczesna K, Iliou MS, Al-Qahtani M, Mobasheri A, Kobolák J, et al. In vitro models of cancer stem cells and clinical applications. BMC Cancer. 2016;16:738.

Article  Google Scholar 

Wang C, Kulkarni P, Salgia R. Combined checkpoint inhibition and chemotherapy: new era of 1st-line treatment for non-small-cell lung cancer. Mol Ther Oncolytics. 2019;13:1–6.

Kamal A, Wessel M, Wyant T, Zhang Q, Alteri R, Lubejko B, et al. Lung cancer—non-small cell: statistics. 2023. https://www.cancer.net/cancer-types/lung-cancer-non-small-cell/statistics.

Zhou J, Wang Y, Wang Y, Yin X, He Y, Chen L, et al. FOXM1 modulates cisplatin sensitivity by regulating EXO1 in ovarian cancer. PLoS ONE. 2014;9:e96989.

Article  PubMed  PubMed Central  Google Scholar 

Zhou C-S, Feng M-T, Chen X, Gao Y, Chen L, Li L-D, et al. Exonuclease 1 (EXO1) is a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma. Onco Targets Ther. 2021;14:1033–48.

Article  PubMed  PubMed Central  Google Scholar 

Liu J, Zhang J. Elevated EXO1 expression is associated with breast carcinogenesis and poor prognosis. Ann Transl Med. 2021;9:135.

Article  PubMed  CAS  PubMed Central  Google Scholar 

Rein K, Yanez DA, Terré B, Palenzuela L, Aivio S, Wei K, et al. EXO1 is critical for embryogenesis and the DNA damage response in mice with a hypomorphic Nbs1 allele. Nucleic Acids Res. 2015;43:7371–87.

Article  PubMed  CAS  PubMed Central  Google Scholar 

He D, Li T, Sheng M, Yang B. Exonuclease 1 (Exo1) participates in mammalian non-homologous end joining and contributes to drug resistance in ovarian cancer. Med Sci Monit. 2020;26:e918751.

Article  PubMed  CAS  PubMed Central  Google Scholar 

Mao P, Wu S, Fan Y. Upregulation of exonuclease 1 caused by homology-dependent repair confers cisplatin resistance to gastric cancer cells. Can J Physiol Pharm. 2022;100:903–14.

Article  CAS  Google Scholar 

Sertic S, Mollica A, Campus I, Roma S, Tumini E, Aguilera A, et al. Coordinated activity of Y family TLS polymerases and EXO1 protects non-S phase cells from UV-induced cytotoxic lesions. Mol Cell. 2018;70:34–47.e4.

Article  PubMed  CAS  Google Scholar 

Pilzecker B, Jacobs H. Mutating for good: DNA damage responses during somatic hypermutation. Front Immunol. 2019;10:438.

Article  PubMed  CAS  PubMed Central  Google Scholar 

Goodman MF, Woodgate R. Translesion DNA polymerases. Cold Spring Harb Perspect Biol. 2013;5:a010363.

Article  PubMed  PubMed Central  Google Scholar 

Srivastava A, Han C, Zhao R, Cui T, Dai Y, Mao H, et al. Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells. Proc Natl Acad Sci USA. 2015;112:4411–6.

Article  PubMed  CAS  PubMed Central  Google Scholar 

Li L, Tian H, Cheng C, Li S, Ming L, Qi L. SiRNA of DNA polymerase iota inhibits the migration and invasion in the lung cancer cell A549. Acta Biochim Biophys Sin. 2018;50:929–33.

Article  PubMed  CAS  Google Scholar 

Zhou HM, Zhang JG, Zhang X, Li Q. Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents. Signal Transduct Target Ther. 2021;6:62.

Article  PubMed  PubMed Central  Google Scholar 

Bartel D. MicroRNA target recognition and regulatory functions. Cell. 2009;136:215–33.

Article  PubMed  CAS  PubMed Central  Google Scholar 

Qiu P, Guo Q, Yao Q, Chen J, Lin J. Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer. PLoS ONE. 2021;16:e0254283.

Article  PubMed  CAS  PubMed Central  Google Scholar 

Delgir S, Ilkhani K, Safi A, Rahmati Y, Montazari V, Zaynali-Khasraghi Z, et al. The expression of miR-513c and miR-3163 was downregulated in tumor tissues compared with normal adjacent tissue of patients with breast cancer. BMC Med Genomics. 2021;14:180.

Article  PubMed  CAS  PubMed Central  Google Scholar 

Ren H, Li Z, Tang Z, Li J, Lang X. Long noncoding MAGI2-AS3 promotes colorectal cancer progression through regulating miR-3163/TMEM106B axis. J Cell Physiol. 2020;235:4824–33.

Article  PubMed  CAS  Google Scholar 

Liu D, Zhang H, Cong J, Cui M, Ma M, Zhang F, et al. H3K27 acetylation-induced lncRNA EIF3J-AS1 improved proliferation and impeded apoptosis of colorectal cancer through miR-3163/YAP1 axis. J Cell Biochem. 2020;121:1923–33.

Article  PubMed  CAS  Google Scholar 

Su L, Han D, Wu J, Huo X. Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163. Tumour Biol. 2015;37:3925–31.

Article  PubMed  Google Scholar 

Zhu W, Yamasaki H, Mironov N. Frequency of HPRT gene mutations induced by N-methyl-N X-nitro-N-nitrosoguanidine corresponds to replication error phenotypes of cell lines. Mutat Res. 1998;398:93–99.

Article  PubMed  CAS  Google Scholar 

Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, et al. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18–27.

Article  PubMed  CAS  PubMed Central  Google Scholar 

Anaya J. OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs. PeerJ Comput Sci. 2016;2:e67.

Article  Google Scholar 

Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47:W556–60.

Article  PubMed  CAS  PubMed Central  Google Scholar 

Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein–protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51:D638–46.

Article  PubMed  CAS  Google Scholar 

Kumar SM, Liu S, Lu H, Zhang H, Zhang PJ, Gimotty PA, et al. Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene. 2012;31:4898–911.

Article  PubMed  CAS  PubMed Central  Google Scholar 

Jeter CR, Liu B, Liu X, Chen X, Liu C, Calhoun-Davis T, et al. NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene. 2011;30:3833–45.

Article  PubMed  CAS  PubMed Central  Google Scholar 

Leis O, Eguiara A, Lopez-Arribillaga E, Alberdi MJ, Hernandez-Garcia S, Elorriaga K, et al. Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene. 2012;31:1354–65.

Article  PubMed  CAS  Google Scholar 

Wang Z, Chao Z, Wang Q, Zou F, Song T, Xu L, et al. EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression. J Transl Med. 2024;22:104.

Article  PubMed  PubMed Central  Google Scholar 

Lin T, Chao C, Saito S, Mazur SJ, Murphy ME, Appella E, et al. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol. 2005;7:165–71.

Article  PubMed  CAS  Google Scholar 

Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, Nakagawa M, et al. Suppression of induced pluripotent stem cell generation by the p53–p21 pathway. Nature. 2009;460:1132–5.

Article  PubMed